Brief: Simcere Pharmaceutical To Issue 121 Million Subscription Shares
02/09/2025 02:18
Sept 2 (Reuters) - Simcere Pharmaceutical Group Ltd 2096.HK: TO ISSUE 121 MILLION SUBSCRIPTION SHARES AT HK$12.95 PER SHARE Further company coverage: 2096.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Simcere Pharmaceutical
See all newsBrief: Simcere Pharmaceutical Announces Approval For Marketing Of Yingmule In China By NMPA
Simcere Pharmaceutical jumps most in two months on Roche tie-up
Roche signs global licensing pact for Simcere's experimental blood cancer drug (updated)
Roche signs global licensing pact for Simcere's B-cell cancer drug candidate
Brief: Simcere Pharmaceutical Enters Exclusive Global Licensing Agreement With Roche For SIM0660